Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amita Gupta

Showing results (301-310 of 328) with videos related to

Pageof 33
Sort By:
Eclinicalmedicine|March 27, 2023
Effect of pregnancy versus postpartum maternal isoniazid preventive therapy on infant growth in HIV-exposed uninfected infants: a post-hoc analysis of the TB APPRISE trialAshenafi S Cherkos, Sylvia M LaCourse, Daniel A Enquobahrie, et al.
Prostaglandins & Other Lipid Mediators|November 15, 2019
Lipid mediators of inflammation and Resolution in individuals with tuberculosis and tuberculosis-DiabetesRupak Shivakoti, Jesmond Dalli, Dileep Kadam, et al.
Plos One|December 6, 2019
Correction: Assessment of lung function in successfully treated tuberculosis reveals high burden of ventilatory defects and COPDAkshay N Gupte, Mandar Paradkar, Sriram Selvaraju, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 25, 2022
Impact of Undernutrition on Tuberculosis Treatment Outcomes in India: A Multicenter, Prospective, Cohort AnalysisPranay Sinha, Chinnaiyan Ponnuraja, Nikhil Gupte, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 25, 2023
1-Year Incidence of Tuberculosis Infection and Disease Among Household Contacts of Rifampin- and Multidrug-Resistant TuberculosisSonya Krishnan, Xingye Wu, Soyeon Kim, et al.
The Lancet Regional Health. Southeast Asia|February 18, 2026
Comprehensive tuberculosis screening and preventive treatment in schools and congregate settings of India (2017-2024): a prospective studyKunchok Dorjee, Sonam Topgyal, Rajesh K Sood, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 29, 2015
Pre-cART Elevation of CRP and CD4+ T-Cell Immune Activation Associated With HIV Clinical Progression in a Multinational Case-Cohort StudyAshwin Balagopal, David M Asmuth, Wei-Teng Yang, et al.
The New England Journal of Medicine|March 14, 2019
One Month of Rifapentine plus Isoniazid to Prevent HIV-Related TuberculosisSusan Swindells, Ritesh Ramchandani, Amita Gupta, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 15, 2015
Toward Earlier Inclusion of Pregnant and Postpartum Women in Tuberculosis Drug Trials: Consensus Statements From an International Expert PanelAmita Gupta, Jyoti S Mathad, Susan M Abdel-Rahman, et al.
Plos One|March 17, 2023
Factors associated with prevalent Mycobacterium tuberculosis infection and disease among adolescents and adults exposed to rifampin-resistant tuberculosis in the householdSoyeon Kim, Anneke C Hesseling, Xingye Wu, et al.
Pageof 33

Showing results (301-310 of 328) with videos related to

Sort By:
Pageof 33
Eclinicalmedicine|March 27, 2023
Effect of pregnancy versus postpartum maternal isoniazid preventive therapy on infant growth in HIV-exposed uninfected infants: a post-hoc analysis of the TB APPRISE trialAshenafi S Cherkos, Sylvia M LaCourse, Daniel A Enquobahrie, et al.
Prostaglandins & Other Lipid Mediators|November 15, 2019
Lipid mediators of inflammation and Resolution in individuals with tuberculosis and tuberculosis-DiabetesRupak Shivakoti, Jesmond Dalli, Dileep Kadam, et al.
Plos One|December 6, 2019
Correction: Assessment of lung function in successfully treated tuberculosis reveals high burden of ventilatory defects and COPDAkshay N Gupte, Mandar Paradkar, Sriram Selvaraju, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 25, 2022
Impact of Undernutrition on Tuberculosis Treatment Outcomes in India: A Multicenter, Prospective, Cohort AnalysisPranay Sinha, Chinnaiyan Ponnuraja, Nikhil Gupte, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 25, 2023
1-Year Incidence of Tuberculosis Infection and Disease Among Household Contacts of Rifampin- and Multidrug-Resistant TuberculosisSonya Krishnan, Xingye Wu, Soyeon Kim, et al.
The Lancet Regional Health. Southeast Asia|February 18, 2026
Comprehensive tuberculosis screening and preventive treatment in schools and congregate settings of India (2017-2024): a prospective studyKunchok Dorjee, Sonam Topgyal, Rajesh K Sood, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 29, 2015
Pre-cART Elevation of CRP and CD4+ T-Cell Immune Activation Associated With HIV Clinical Progression in a Multinational Case-Cohort StudyAshwin Balagopal, David M Asmuth, Wei-Teng Yang, et al.
The New England Journal of Medicine|March 14, 2019
One Month of Rifapentine plus Isoniazid to Prevent HIV-Related TuberculosisSusan Swindells, Ritesh Ramchandani, Amita Gupta, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 15, 2015
Toward Earlier Inclusion of Pregnant and Postpartum Women in Tuberculosis Drug Trials: Consensus Statements From an International Expert PanelAmita Gupta, Jyoti S Mathad, Susan M Abdel-Rahman, et al.
Plos One|March 17, 2023
Factors associated with prevalent Mycobacterium tuberculosis infection and disease among adolescents and adults exposed to rifampin-resistant tuberculosis in the householdSoyeon Kim, Anneke C Hesseling, Xingye Wu, et al.
Pageof 33